GENE Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $2.32 = $23.2
GENE Charts
GENE Prices
View the GENE historical prices.
52WL $1.80
The 52 Week Low is $1.80 set on Fri, Jan 6, 2023.
52WH $147.50
The 52 Week High is $147.50 set on Tue, Mar 1, 2022. The current price, $2.32, is 0% below the 52 Week High.
ATH $277.00
The All-Time High is $277.00 set on Mon, Nov 7, 2005. The current price, $2.32, is 0% below the All Time High.
52 Week Range
GENE Dividends
GENE has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
GENE Profile
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
